These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15160803)

  • 21. Economic impact of disease prevention in a morbidity-based financing system: does prevention pay off for a statutory health insurance fund in Germany?
    Weinhold I; Schindler C; Kossack N; Berndt B; Häckl D
    Eur J Health Econ; 2019 Nov; 20(8):1181-1193. PubMed ID: 31317353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Consumer price sensitivity and social health insurer choice in Germany and The Netherlands.
    Schut FT; Gress S; Wasem J
    Int J Health Care Finance Econ; 2003 Jun; 3(2):117-38. PubMed ID: 14626009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Individual healthcare services in the ambulatory sector].
    Klakow-Franck R
    Z Arztl Fortbild Qualitatssich; 2006; 100(9-10):703-6; discussion 723-4. PubMed ID: 17269510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. German risk structure compensation: enhancing equity and effectiveness.
    Files A; Murray M
    Inquiry; 1995; 32(3):300-9. PubMed ID: 7591043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Market Concentration in the Statutory Health Insurance of Germany since the Introduction of Free Choice of Sickness Funds].
    Götze R
    Gesundheitswesen; 2016 Nov; 78(11):715-720. PubMed ID: 25760099
    [No Abstract]   [Full Text] [Related]  

  • 26. [Competition among health insurers from the perspective of a statutory health insurance company].
    Fischer B
    Z Evid Fortbild Qual Gesundhwes; 2009; 103(10):635-8; discussion 643. PubMed ID: 20120192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring Health System Responsiveness in Ambulatory Care and Disease Management and its Relation to Other Dimensions of Health System Performance (RAC) - Study Design and Methodology.
    Röttger J; Blümel M; Engel S; Grenz-Farenholtz B; Fuchs S; Linder R; Verheyen F; Busse R
    Int J Health Policy Manag; 2015 May; 4(7):431-7. PubMed ID: 26188807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Quality assurance and quality management in medical rehabilitation].
    Farin E; Jäckel WH
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Feb; 54(2):176-84. PubMed ID: 21290272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk selection in the German public health insurance system.
    Nuscheler R; Knaus T
    Health Econ; 2005 Dec; 14(12):1253-71. PubMed ID: 15942977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Universal health insurance and high-risk groups in West Germany: implications for U.S. health policy.
    Wysong JA; Abel T
    Milbank Q; 1990; 68(4):527-60. PubMed ID: 2292990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetes--prevalence and cost of illness in Germany: a study evaluating data from the statutory health insurance in Germany.
    Stock SA; Redaelli M; Wendland G; Civello D; Lauterbach KW
    Diabet Med; 2006 Mar; 23(3):299-305. PubMed ID: 16492214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shepherding major health system reforms: a conversation with German health minister Ulla Schmidt. Interview by Tsung-Mei Cheng and Uwe Reinhardt.
    Schmidt U
    Health Aff (Millwood); 2008; 27(3):w204-13. PubMed ID: 18397935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The well-informed patient from the statutory health insurance standpoint].
    Wöllenstein H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Oct; 47(10):941-9. PubMed ID: 15521111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Health care cantonal compensation fund project].
    Imsand C
    Rev Med Suisse; 2016 Mar; 12(509):527. PubMed ID: 27089648
    [No Abstract]   [Full Text] [Related]  

  • 35. Addressing the "chronification" of disease.
    Chernew ME
    Am J Manag Care; 2017 Feb; 23(2):87-88. PubMed ID: 28245656
    [No Abstract]   [Full Text] [Related]  

  • 36. [Free choice of doctors in Germany in retrospect].
    Kunstmann W; Butzlaff M; Böcken J
    Gesundheitswesen; 2002 Mar; 64(3):170-5. PubMed ID: 11904859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Competition policy for health care provision in Germany.
    Kifmann M
    Health Policy; 2017 Feb; 121(2):119-125. PubMed ID: 27908564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Quality assurance after the Health Reform Legislation].
    Sendler H
    Offentl Gesundheitswes; 1991 Mar; 53(3):124-8. PubMed ID: 1827885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. German unification and European integration.
    Deppe HU
    Health PAC Bull; 1992; 22(1):22-7. PubMed ID: 10118785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Between the lines.
    Moran M
    Health Serv J; 1992 Apr; 102(5299):20-3. PubMed ID: 10118326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.